000 | 01159 a2200325 4500 | ||
---|---|---|---|
005 | 20250514031958.0 | ||
264 | 0 | _c20020613 | |
008 | 200206s 0 0 eng d | ||
022 | _a0007-1250 | ||
024 | 7 |
_a10.1192/bjp.180.5.466-a _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWalsh, E | |
245 | 0 | 0 |
_aProlonged QT interval with rivastigmine. _h[electronic resource] |
260 |
_bThe British journal of psychiatry : the journal of mental science _cMay 2002 |
||
300 |
_a466 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
650 | 0 | 4 |
_aCarbamates _xadverse effects |
650 | 0 | 4 |
_aCholinesterase Inhibitors _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLong QT Syndrome _xchemically induced |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNeuroprotective Agents _xadverse effects |
650 | 0 | 4 | _aPhenylcarbamates |
650 | 0 | 4 | _aRivastigmine |
700 | 1 | _aDourish, J | |
773 | 0 |
_tThe British journal of psychiatry : the journal of mental science _gvol. 180 _gp. 466 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1192/bjp.180.5.466-a _zAvailable from publisher's website |
999 |
_c11883820 _d11883820 |